Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients (vol 51, pg 594, 2018)

被引:1
|
作者
Dhaese, Sofie A. M. [1 ]
Roberts, Jason A. [2 ,3 ,4 ]
Carlier, Mieke [5 ]
Verstraete, Alain G. [5 ,6 ]
Stove, Veronique [5 ,6 ]
De Waele, Jan J. [1 ]
机构
[1] Ghent Univ Hosp, Intens Care, C Heymanslaan 10, B-9000 Ghent, Belgium
[2] Univ Queensland, Fac Med, Brisbane, Qld, Australia
[3] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
[4] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[5] Ghent Univ Hosp, Lab Med, Ghent, Belgium
[6] Univ Ghent, Clin Chem Microbiol & Immunol, Ghent, Belgium
关键词
D O I
10.1016/j.ijantimicag.2019.07.022
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:380 / 380
页数:1
相关论文
共 50 条
  • [21] Population pharmacokinetics of piperacillin-tazobactam in the plasma and cerebrospinal fluid of critically ill patients
    Kumta, Nilesh
    Heffernan, Aaron J.
    Cotta, Menino Osbert
    Liu, Xin
    Parker, Suzanne
    Wallis, Steven
    Livermore, Amelia
    Starr, Therese
    Wong, Wai Tat
    Joynt, Gavin M.
    Lipman, Jeffrey
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2025, 69 (02)
  • [22] Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study (vol 52, pg 75, 2019)
    Dhaese, Sofie A. M.
    Thooft, Alexander D. J.
    Farkas, Andras
    Lipman, Jeffrey
    Verstraete, Alain G.
    Stove, Veronique
    Roberts, Jason A.
    De Waele, Jan J.
    JOURNAL OF CRITICAL CARE, 2020, 56 : 325 - 325
  • [23] POPULATION PHARMACOKINETICS (PK) OF PIPERACILLIN/TAZOBACTAM (TZP) IN CRITICALLY ILL CHILDREN
    Cies, Jeffrey
    Shankar, Venkat
    Schlichting, Christine
    Kuti, Joseph
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U31 - U31
  • [24] Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients
    Rafati, Mohammad Reza
    Rouini, Mohammad Reza
    Mojtahedzadeh, Mojtaba
    Najafi, Atabak
    Tavakoji, Hassan
    Gholami, Kheirollah
    Fazeli, Mohammad Reza
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (02) : 122 - 127
  • [25] Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy
    Butragueno-Laiseca, Laura
    Marco-Arino, Nicolas
    Troconiz, Inaki F.
    Grau, Santiago
    Campillo, Nuria
    Garcia, Xandra
    Padilla, Belen
    Fernandez, Sarah Nicole
    Slocker, Maria
    Santiago, Maria Jose
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (09) : 1287.e9 - 1287.e15
  • [26] Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT
    Shotwell, Matthew S.
    Nesbitt, Ross
    Madonia, Phillip N.
    Gould, Edward R.
    Connor, Michael J.
    Salem, Charbel
    Aduroja, Olufemi A.
    Amde, Milen
    Groszek, Joseph J.
    Wei, Peilin
    Taylor, Maria E.
    Tolwani, Ashita J.
    Fissell, William H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (08): : 1377 - 1383
  • [27] Population Pharmacokinetic of Vancomycin Administered by Continuous Infusion in Critically Ill Patients
    Ben Romdhane, Haifa
    Woillard, Jean Baptiste
    Ben Fadhel, Najah
    Chadli, Zohra
    Chaabane, Amel
    Boughattas, Naceur
    Ben Fredj, Nadia
    Aouam, Karim
    PHARMACOLOGY, 2024,
  • [28] Pharmacokinetics of an Extended 4-hour Infusion of Piperacillin-Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Awissi, Don-Kelena
    Beauchamp, Annie
    Hebert, Elisabeth
    Lavigne, Viviane
    Munoz, Danya Lucia
    Lebrun, Genevieve
    Savoie, Michel
    Fagnan, Mylene
    Amyot, Julie
    Tetreault, Nicolas
    Robitaille, Robert
    Varin, France
    Lavallee, Christian
    Pichette, Vincent
    Leblanc, Martine
    PHARMACOTHERAPY, 2015, 35 (06): : 600 - 607
  • [29] Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients
    Swart, EL
    Zuideveld, KP
    de Jongh, J
    Danhof, M
    Thijs, LG
    van Schijndel, RMJS
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (02) : 135 - 145
  • [30] PHARMACOKINETICS OF MIDAZOLAM DURING CONTINUOUS INFUSION IN CRITICALLY ILL NEONATES
    JACQZAIGRAIN, E
    DAOUD, P
    BURTIN, P
    MAHERZI, S
    BEAUFILS, F
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (03) : 329 - 332